Form SC 13G/A IMMUNOGEN INC Filed by: BlackRock Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Immunogen (IMGN) Tops Q2 EPS by 21c
January 30, 2015 6:32 AM ESTImmunogen (NASDAQ: IMGN) reported Q2 EPS of $0.16, $0.21 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $48.3 million versus the consensus estimate of $37.3 million.
Financial Guidance for Fiscal Year 2015
ImmunoGens financial guidance remains unchanged from that issued in... More
